Physician profile
Matthew W Reed
NPI 1225219264
$17,301.34
in general payments reported to CMS, 2019-2025
50 companies · $2,870 in 2025
The $2,870 reported for 2025 was more than what 85% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,945 · 2020: $1,047 · 2021: $1,018 · 2022: $1,802 · 2023: $1,927 · 2024: $6,692 · 2025: $2,870.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $5,500 · Food and Beverage: $5,473 · Travel and Lodging: $516.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $5,500.00 |
| Food and Beverage | $5,473.04 |
| Travel and Lodging | $516.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,245.57 | 2023-2025 | |
| Allergan, INC. | $1,850.99 | 2019-2022 | |
| Integra Lifesciences Corporation | $1,750.17 | 2019-2025 | Integra, Durasorb Monofilament Mesh, Omnigraft |
| Abbvie INC. | $1,465.93 | 2021-2025 | |
| Davol INC. | $692.66 | 2022-2024 | Phasix Mesh |
| Smith+Nephew, INC. | $489.50 | 2019-2025 | Grafix Pl, Renasys Go V2 Home, Oasis |
| Ethicon US, LLC | $437.72 | 2019-2025 | Echelon; Endopath, Stratafix, Surgiflo Hemostatic Matrix |
| Innovation Technologies INC | $413.45 | 2021-2024 | Irrisept |
| Cumberland Pharmaceuticals, INC. | $357.46 | 2019-2023 | Vibativ |
| Kerecis Limited | $353.68 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Organogenesis INC. | $331.23 | 2019-2022 | |
| Acell, INC. | $232.47 | 2020 | |
| Paratek Pharmaceuticals, INC. | $216.35 | 2019-2021 | |
| Avita Medical Americas, LLC | $190.58 | 2024-2025 | Permeaderm, Recell, Cohealyx |
| Acera Surgical, INC. | $190.54 | 2019-2020 |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $182.37 | 2022-2023 | Seglentis |
| Conmed Corporation | $156.25 | 2019-2023 | Airseal, Conmed Specimen Retrieval |
| Osiris Therapeutics INC. | $145.32 | 2019 | |
| Medtronic, INC. | $139.43 | 2023-2025 | Maxtack, Sonicision, Reliatack |
| Becton, Dickinson and Company | $139.23 | 2019 | |
| Medline Industries LP | $139.10 | 2019 | |
| Tei Biosciences INC | $137.35 | 2019 | |
| Medela LLC | $119.53 | 2024 | Invia Motion Endure |
| Mimedx Group, INC. | $95.08 | 2025 | |
| Braintree Laboratories, INC. | $71.58 | 2023-2024 | Sutab, Suflave |
| Melinta Therapeutics, LLC | $69.03 | 2022-2024 | Orbactiv, Kimyrsa |
| Solventum Corporation | $61.70 | 2024-2025 | Activ.A.C., V.A.C.Ulta |
| Urgo Medical North America, LLC | $55.14 | 2024-2025 | Urgoclean Ag |
| Takeda Pharmaceuticals U.S.A., INC. | $47.43 | 2022 | |
| Hologic Sales and Service, LLC | $46.29 | 2023-2024 | Localizer, Trunode, Aptima |
| Boston Scientific Corporation | $44.23 | 2025 | Spyglass Discover |
| Biocomposites INC | $40.80 | 2025 | Stimulan |
| Tela Bio, INC. | $39.33 | 2020 | |
| Polynovo North America LLC | $38.68 | 2022 | |
| Teleflex LLC | $32.34 | 2021-2024 | Deknatel |
| Covidien LP | $29.50 | 2019 | |
| Cardinal Health 200 LLC | $23.42 | 2019 | |
| Hollister Incorporated | $22.47 | 2025 | New Image |
| Asensus Surgical, INC. | $22.26 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $21.70 | 2025 | |
| Next Science LLC | $19.98 | 2022 | |
| Innocoll Pharmaceuticals Limited | $18.53 | 2022 | |
| Heron Therapeutics, INC. | $18.06 | 2021 | |
| Baudax Bio INC. | $17.61 | 2020 | |
| Convatec INC. | $17.01 | 2019 | |
| Bioventus LLC | $16.33 | 2022 | |
| Depuy Synthes Sales INC. | $15.92 | 2022 | |
| Misonix INC | $14.30 | 2019 | |
| Lsi Solutions INC | $13.63 | 2021 | |
| Shire North American Group INC | $12.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Reed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.